113 related articles for article (PubMed ID: 16640027)
1. In vitro inactivation of rat brain acetylcholinesterase by DSP-4 and its derivatives OS-21 and OS-23 and protective activity of tacrine (9-amino-1,2,3,4-tetrahydroacridine).
Patockal J; Jun D; Kucal K
Acta Medica (Hradec Kralove); 2005; 48(3-4):145-8. PubMed ID: 16640027
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
[TBL] [Abstract][Full Text] [Related]
3. O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation.
Mao F; Huang L; Luo Z; Liu A; Lu C; Xie Z; Li X
Bioorg Med Chem; 2012 Oct; 20(19):5884-92. PubMed ID: 22944335
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of huperzine B on cholinesterase activity in mice.
Liu J; Zhang HY; Wang LM; Tang XC
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):141-5. PubMed ID: 10437161
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
[TBL] [Abstract][Full Text] [Related]
6. SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.
Recanatini M; Cavalli A; Belluti F; Piazzi L; Rampa A; Bisi A; Gobbi S; Valenti P; Andrisano V; Bartolini M; Cavrini V
J Med Chem; 2000 May; 43(10):2007-18. PubMed ID: 10821713
[TBL] [Abstract][Full Text] [Related]
7. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes.
Nielsen JA; Mena EE; Williams IH; Nocerini MR; Liston D
Eur J Pharmacol; 1989 Nov; 173(1):53-64. PubMed ID: 2606156
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of multiple molecular forms of human brain acetylcholinesterase by different types of inhibitors.
Bajgar J; Máté L
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1989; 32(4):425-35. PubMed ID: 2637489
[TBL] [Abstract][Full Text] [Related]
9. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
Wang H; Tang XC
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):27-30. PubMed ID: 10375753
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.
Hamulakova S; Janovec L; Hrabinova M; Kristian P; Kuca K; Banasova M; Imrich J
Eur J Med Chem; 2012 Sep; 55():23-31. PubMed ID: 22818849
[TBL] [Abstract][Full Text] [Related]
11. Effects of tacrine (THA) on spatial reference memory and cholinergic enzymes in specific rat brain regions.
Jackson JJ; Soliman MR
Life Sci; 1996; 58(1):47-54. PubMed ID: 8628110
[TBL] [Abstract][Full Text] [Related]
12. Comparative effect of Prunus persica L. BATSCH-water extract and tacrine (9-amino-1,2,3,4-tetrahydroacridine hydrochloride) on concentration of extracellular acetylcholine in the rat hippocampus.
Kim YK; Koo BS; Gong DJ; Lee YC; Ko JH; Kim CH
J Ethnopharmacol; 2003 Aug; 87(2-3):149-54. PubMed ID: 12860300
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine.
Marquis JK
Biochem Pharmacol; 1990 Sep; 40(5):1071-6. PubMed ID: 2390104
[TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity using variable selections.
Jung M; Tak J; Lee Y; Jung Y
Bioorg Med Chem Lett; 2007 Feb; 17(4):1082-90. PubMed ID: 17158047
[TBL] [Abstract][Full Text] [Related]
15. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
[TBL] [Abstract][Full Text] [Related]
16. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current.
Drukarch B; Kits KS; Van der Meer EG; Lodder JC; Stoof JC
Eur J Pharmacol; 1987 Sep; 141(1):153-7. PubMed ID: 2444444
[TBL] [Abstract][Full Text] [Related]
17. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
Berman HA; Leonard K
Mol Pharmacol; 1992 Feb; 41(2):412-8. PubMed ID: 1538717
[TBL] [Abstract][Full Text] [Related]
18. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
El-Malah A; Gedawy EM; Kassab AE; Salam RM
Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamic analysis of human retinal acetylcholinesterase inhibition using an anti-Alzheimer's drug, tacrine, through the development of a dual substrate and temperature model.
Kamal MA; Alhomida AS; Al-Rajhi AA; Al-Jafari AA
Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):108-15. PubMed ID: 10943943
[TBL] [Abstract][Full Text] [Related]
20. Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation inhibitors.
Tang H; Zhao LZ; Zhao HT; Huang SL; Zhong SM; Qin JK; Chen ZF; Huang ZS; Liang H
Eur J Med Chem; 2011 Oct; 46(10):4970-9. PubMed ID: 21871694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]